| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,000 |
23,170 |
$1.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,793 |
17,117 |
$1.20M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,941 |
1,854 |
$145K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,976 |
1,479 |
$118K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,367 |
1,298 |
$102K |
| 36415 |
Collection of venous blood by venipuncture |
3,050 |
2,625 |
$48K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,276 |
3,050 |
$40K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
339 |
316 |
$40K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
465 |
449 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,535 |
2,327 |
$35K |
| 90670 |
|
1,202 |
1,044 |
$22K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
988 |
953 |
$21K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,095 |
3,912 |
$19K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,854 |
973 |
$18K |
| 87428 |
|
373 |
314 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,149 |
629 |
$17K |
| 99188 |
|
755 |
724 |
$15K |
| 20610 |
|
737 |
395 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
236 |
195 |
$12K |
| 81025 |
|
352 |
175 |
$11K |
| 90686 |
|
1,187 |
1,106 |
$11K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
511 |
362 |
$10K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
942 |
696 |
$9K |
| 3074F |
|
2,391 |
2,016 |
$9K |
| 90723 |
|
701 |
642 |
$9K |
| 3078F |
|
2,522 |
2,083 |
$9K |
| 83655 |
|
866 |
799 |
$8K |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
239 |
195 |
$7K |
| 3008F |
|
4,414 |
3,571 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
223 |
204 |
$7K |
| 90651 |
|
203 |
192 |
$7K |
| 90647 |
|
654 |
596 |
$7K |
| 92587 |
|
548 |
494 |
$7K |
| 90633 |
|
572 |
526 |
$7K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
39 |
12 |
$5K |
| 3079F |
|
1,365 |
1,220 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
204 |
154 |
$5K |
| 90674 |
|
291 |
245 |
$4K |
| 85027 |
|
134 |
128 |
$4K |
| 99000 |
|
1,316 |
1,191 |
$4K |
| 90734 |
|
193 |
177 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
126 |
113 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
112 |
79 |
$3K |
| 3075F |
|
952 |
847 |
$3K |
| 94060 |
|
251 |
244 |
$3K |
| 99173 |
|
1,349 |
1,236 |
$3K |
| 3077F |
|
975 |
829 |
$3K |
| 85018 |
|
1,157 |
1,072 |
$3K |
| 90710 |
|
105 |
101 |
$3K |
| 90681 |
|
157 |
141 |
$2K |
| 90656 |
|
53 |
39 |
$2K |
| 94726 |
|
183 |
181 |
$2K |
| 94729 |
|
185 |
183 |
$2K |
| 90696 |
|
127 |
112 |
$2K |
| 90621 |
|
52 |
44 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
40 |
24 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
65 |
51 |
$1K |
| 99205 |
Prolong outpt/office vis |
14 |
13 |
$1K |
| 87807 |
|
93 |
85 |
$1K |
| 90715 |
|
91 |
85 |
$1K |
| 99307 |
|
111 |
74 |
$922.20 |
| 99306 |
Prolong nursin fac eval 15m |
17 |
12 |
$855.92 |
| 90961 |
|
37 |
25 |
$821.39 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
19 |
15 |
$773.80 |
| 90716 |
|
43 |
37 |
$735.65 |
| 90756 |
|
111 |
82 |
$697.94 |
| 90688 |
|
134 |
124 |
$620.19 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18 |
12 |
$549.24 |
| 99215 |
Prolong outpt/office vis |
17 |
14 |
$521.05 |
| 3080F |
|
258 |
225 |
$490.15 |
| 90707 |
|
26 |
24 |
$448.66 |
| 99441 |
|
33 |
30 |
$414.54 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$373.08 |
| 92551 |
|
39 |
36 |
$363.20 |
| 36416 |
|
22 |
18 |
$210.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$206.56 |
| 90700 |
|
18 |
15 |
$182.90 |
| 90698 |
|
19 |
16 |
$140.49 |
| 90680 |
|
18 |
15 |
$140.49 |
| 81002 |
|
38 |
37 |
$107.85 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$100.78 |
| G0008 |
Administration of influenza virus vaccine |
73 |
59 |
$93.76 |
| 90744 |
|
15 |
13 |
$68.53 |
| 86308 |
|
12 |
12 |
$68.19 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
17 |
12 |
$61.57 |
| 4004F |
|
137 |
127 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
235 |
207 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
194 |
167 |
$0.00 |
| 91300 |
|
35 |
13 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
14 |
12 |
$0.00 |